▲ Peaking
Business
Eli Lilly CEO reveals astonishing shift in GLP-1 pill market
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Lilly
37 trends tracked about this subject — the full history, oldest to newest below.
▲ Peaking
Business
GLP-1 makers Novo, Eli Lilly sued over sudden loss of vision in patients
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
↑ Rising
Business
Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
Eli Lilly is breaking ground in Houston on a facility planned for 2030
Eli Lilly plans a 2030 groundbreaking in Houston as weight-loss drug developers line up to tap a lucrative and increasingly competitive market.
◼ Archived
Business
Novo says CagriSema shows greater weight loss than Lilly rival in diabetes patients
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs
Novo Nordisk shares slide despite aggressive obesity targets as investors demand a broader long-term strategy.
◼ Archived
Health
Novo Nordisk (NVO) and Eli Lilly (LLY)’s Weight-Loss Drugs Still Work at Smaller Doses, Study Finds
Recent studies indicate that popular weight-loss treatments manufactured by Novo Nordisk and Eli Lilly retain efficacy at reduced doses.
◼ Archived
Entertainment
🔮 fades ✓
J.K. Rowling’s rep responds to Lilly Wachowski’s accusation of ‘funding trans genocide’ (exclusive)
1 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Novartis pelacarsen Lp(a) trial fails, raising doubts for Amgen, Lilly
Novartis experiences a trial failure with pelacarsen, impacting the Dow and raising questions for competitors like Amgen and Lilly.
◼ Archived
Business
🔮 fades ✗
Lilly’s dealmaking spreads the wealth among a broad set of biotech venture investors
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Lilly snags another Massachusetts biotech as local headcount surges past 1,400
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✗
Eli Lilly inks $2.88B Merida buyout for autoimmune drugs against rogue antibodies
8 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
US FDA approves Lilly's Mounjaro to reduce cardiovascular risk
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Lilly files six lawsuits in bid to shut down ‘black market’ for retatrutide
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Eli Lilly is suing six companies over illegal sales of its unapproved weight loss drug
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Entertainment
🔮 fades ✗
‘The Matrix’ Director Lilly Wachowski Says Hollywood Won’t Finance Her $10 Million Thriller Because It’s Got a ‘Wall-to-Wall Trans Cast’
5 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
CVS Health Launches Eli Lilly GLP-1 Partnership, Lifts Outlook as Profit Increases
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✗
Eli Lilly Posts Higher Revenue on Continued GLP-1 Demand
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✗
Lilly reports second-quarter 2026 financial results, raises full-year guidance, and highlights continued growth and pipeline progress
Eli Lilly’s 48% revenue surge eclipses a weak earnings report from The Trade Desk, reshaping market expectations for biotech and ad tech alike.
◼ Archived
Business
🔮 holds ✓
Eli Lilly to allow more patients to apply for special access to unapproved obesity drug
10 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Entertainment
🔮 fades ✓
Where Ethan Slater stands with ex-wife Lilly Jay after Ariana Grande breakup: report
6 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades
Lilly’s triple-G drug hits 22.6% weight loss, but impact on reducing cardio risk is less clear
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades
Eli Lilly’s Anticipated Weight Loss Drug Helped People Lose 56 Pounds On Average
Eli Lilly's retatrutide shows significant weight loss results in Phase 3 trials, paving the way for a 2027 FDA approval filing.
◼ Archived
Business
🔮 fades
Eli Lilly says it will file for approval of next-generation obesity drug in 2027 as it clears two more trials
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 holds
Novo sues Lilly, claiming misleading ads in weight-loss drug battle
Novo Nordisk has filed a lawsuit against Eli Lilly over allegations of deceptive and misleading advertising regarding GLP-1 weight-loss drugs.
◼ Archived
Health
🔮 fades
The Next Wave Of Peptides Could Be Here; What Does It Mean For Lilly, Novo?
FDA’s new peptide panel sparks regulatory debate as biotech giants Lilly and Novo eye the next health wave.
◼ Archived
Business
🔮 fades
Lilly buys AtaiBeckley for $2.8B upfront to challenge J&J for psychedelic mental health market
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades
Eli Lilly's Market Cap Balloons, Again, On This IPO's Setback
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades
The loophole in Trump’s obesity drug deal with Eli Lilly and Novo Nordisk
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades
Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades
Eli Lilly Leads 5 Stocks Near Buy Points As The Market Rally Rotates
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades
Lilly, J&J and AbbVie Hit New Highs
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades
Eli Lilly and Company (LLY) CEO on How GLP-1s Will Reshape America
Oral GLP-1 medications are gaining attention as clinical data emerges regarding their efficacy in weight management and potential to shift treatment paradigms.
◼ Archived
Business
🔮 fades
Sangamo to put ‘substantially all’ assets for sale in bankruptcy, lines up Lilly and Astellas as buyers
8 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.